• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.

作者信息

Schneider P J

机构信息

College of Pharmacy, Ohio State Univ., Columbus 43210, USA.

出版信息

Pharm Pract Manag Q. 1998 Jul;18(2):32-6.

PMID:10185237
Abstract

Biotechnology products offer both problems and opportunities for pharmacists. On one hand, they are expensive to purchase and keep on inventory. Typical compensation for outpatient prescriptions does not offset the cost of maintaining the inventory, or providing the education and training that patients often need to use biotechnology products properly. On the other hand, there are issues related to proper storage, preparation, and administration for which pharmacists are well prepared to address. Pharmacists are also convenient, trusted, and provide service at relatively low cost. Examples of special services that pharmacists can provide to improve the use of biotechnology products include patient education, injection clinics, provision of medical supplies, and predrawing syringes for patients. Patients are often sent to many providers for these services, resulting in inconvenience and fragmentation of care. If new compensation methods can be established to support more comprehensive pharmacy services, the use of biotechnology products by patients will improve.

摘要

相似文献

1
Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.
Pharm Pract Manag Q. 1998 Jul;18(2):32-6.
2
Pharmaceutical care in community pharmacies: practice and research in Sweden.社区药房的药学服务:瑞典的实践与研究
Ann Pharmacother. 2006 Jun;40(6):1162-9. doi: 10.1345/aph.1G680. Epub 2006 May 30.
3
Specialty pharmaceuticals: developing a management plan.专科药物:制定管理计划。
Manag Care Q. 2002 Fall;10(4):26-9.
4
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.政策与实践:医疗和教育环境中处方治疗与耐用医疗设备的比较
Pediatrics. 2004 Nov;114(5):e612-25. doi: 10.1542/peds.2004-1063.
5
The pharmacoeconomics of high-cost biotechnology products.高成本生物技术产品的药物经济学
Pharm Pract Manag Q. 1998 Jul;18(2):23-31.
6
Biotechnology products: new opportunities and responsibilities for the pharmacist.生物技术产品:药剂师面临的新机遇与责任
Am J Hosp Pharm. 1989 Nov;46(11 Suppl 2):S4-8.
7
Current state of community pharmacy in Japan: practice, research, and future opportunities or challenges.日本社区药房的现状:实践、研究及未来机遇或挑战。
Ann Pharmacother. 2006 Nov;40(11):2008-14. doi: 10.1345/aph.1H221. Epub 2006 Oct 24.
8
The effects of managed care on the retail distribution of pharmaceuticals.管理式医疗对药品零售分销的影响。
Manag Care Interface. 1998 Nov;11(11):105-8, 111-3.
9
Pharmaceutical care in community pharmacies: practice and research in the US.社区药房的药学服务:美国的实践与研究
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1400-6. doi: 10.1345/aph.1G545.
10
Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.生物技术:工具、治疗剂及其在药学实践中的应用概述。
Pharm Pract Manag Q. 1998 Jul;18(2):1-12.